Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Endometrial Neoplasms 7Lymphatic Metastasis 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 3Breast Neoplasms 3Thyroid Cancer, Papillary 2Stomach Neoplasms 2Prostatic Neoplasms 2Postoperative Complications 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphedema 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Uterine Neoplasms 1Urologic Neoplasms 1Ureteral Neoplasms 1Thyroid cancer, follicular 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Recurrence 1Radiation Injuries 1Prostate Adenocarcinoma 1Platelet Glycoprotein IV Deficiency 1Parotid Neoplasms 1

Interventions

Cisplatin 161Fluorouracil 135Paclitaxel 127Radiotherapy 125Oxaliplatin 88Docetaxel 71Carboplatin 71Irinotecan 60pembrolizumab 57Leucovorin 57Capecitabine 57Radiation 48Esophagectomy 44Surgical Procedures, Operative 41Drug Therapy 38Neoadjuvant Therapy 28Cetuximab 25Nivolumab 24Bevacizumab 21camrelizumab 20Trastuzumab 20S 1 (combination) 19Chemoradiotherapy 19Magnetic Resonance Spectroscopy 18Epirubicin 16Albumin-Bound Paclitaxel 16Blood Specimen Collection 15tislelizumab 14Taxes 14Radiotherapy, Intensity-Modulated 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Lymph Node Excision × Clear all
NCT07519486 2026-04-15

INS-ESCC-CT

Sichuan University

Phase 2 Recruiting
118 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01807936 2023-07-20

Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)

Fudan University

Phase NA Completed
400 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡